Phase I Study of Olaparib and Temozolomide in Adult Patients With Recurrent/Metastatic Ewing's Sarcoma Following Failure of Prior Chemotherapy
Phase of Trial: Phase I
Latest Information Update: 14 Jun 2018
At a glance
- Drugs Irinotecan (Primary) ; Olaparib (Primary) ; Temozolomide (Primary)
- Indications Ewing's sarcoma
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 08 Jun 2018 Planned End Date changed from 1 Jul 2019 to 1 Jul 2020.
- 08 Jun 2018 Planned primary completion date changed from 1 Jul 2018 to 1 Jul 2019.